InvestorLens

ABT — ABBOTT LABORATORIES

Health Care

Sign in to save6 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About ABBOTT LABORATORIES (ABT)

ABBOTT LABORATORIES (ABT) appears in the most recent 13F filings of 6 tracked institutional investors. ABBOTT LABORATORIES is classified in the Health Care sector. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $392M. Across recent filings, tracked investors recorded 9 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in ABT

100
/100
Strong Institutional Accumulation
Added / Increased9
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track ABT

40
/100
Moderate Interest
6investors

Several tracked investors have exposure.

UndiscoveredCrowded
151015+

ABT Ownership Composition

How ABBOTT LABORATORIES is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
95% of tracked value
Institutions
6
tracked investors
Total Reported
$696.5M
combined 13F value
Sectors2
  • Other94.8%
  • Hedge Funds5.2%
Other(4)
94.8%
Hedge Funds(2)
5.2%

Tracked investors reporting ABT

  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    3.8M
    Value
    $392.2M
    % Portfolio
    0.06%
  • Izzy EnglanderMar 31, 2026
    Millennium Management
    Shares
    1.9M
    Value
    $193.7M
    % Portfolio
    0.08%
  • Paul Tudor JonesMar 31, 2026
    Tudor Investment Corp
    Shares
    610.1K
    Value
    $62.6M
    % Portfolio
    0.12%
  • Steve CohenMar 31, 2026
    Point72 Asset Management
    Shares
    304.8K
    Value
    $31.3M
    % Portfolio
    0.04%
  • Ray DalioMar 31, 2026
    Bridgewater Associates
    Shares
    117.1K
    Value
    $12M
    % Portfolio
    0.05%
  • George SorosMar 31, 2026
    Soros Fund Management
    Shares
    44.8K
    Value
    $4.6M
    % Portfolio
    0.05%

Recent activity

Frequently asked questions

How many institutional investors hold ABT?
6 tracked institutional investors disclosed a position in ABT (ABBOTT LABORATORIES) in their most recent 13F filing.
Who is the largest institutional holder of ABT?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in ABT, valued at $392M.
Did institutional ownership of ABT increase or decrease?
Across recent 13F filings, tracked investors recorded 9 new positions, 0 increased, 0 reduced, and 0 fully exited ABT.
What sector is ABT in?
ABBOTT LABORATORIES is classified in the Health Care GICS sector.
Where does this ABT ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.